SFTPA1 and lung carcinoma: As shown in Fig. 8b, the positive SFTPA1 expression group exhibited a higher partial response (PR) rate than the negative group in all lung cancer patients (positive vs negative; PR: 67% vs 50%), and a lower progressive disease (PD) rate (0% vs 17%).